Mechanisms of bone loss after cardiac transplantation

Bone

Volumn 22, Issue 3, 1998, Pages 267-271

  Guo, C Y ^a   Johnson, A ^a   Locke, T J ^b   Eastell, R ^a,b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Bone turnover; Cardiac transplantation; Corticosteroids; Cyclosporin; Osteoporosis; Secondary hyperparathyroidism

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; CALCITRIOL; CALCIUM; COLLAGEN TYPE 1; CREATININE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHORUS; PRASTERONE; PREDNISOLONE; TESTOSTERONE;

ADULT; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MINERAL; BONE TURNOVER; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMUR NECK; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; LUMBAR SPINE; MALE; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BONE DENSITY; BONE DEVELOPMENT; BONE RESORPTION; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; HYPERTHYROIDISM; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; OSTEOPOROSIS; PARATHYROID HORMONE;

EID: 0032030504     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(97)00269-X     Document Type: Article

References (33)

1. 1. Aubia, J., Masramon, J., Serrano, S., Lloveras, J., and Marinoso, L. Bone histology in renal transplant patients receiving cyclosporine. Lancet i: 1048-1049; 1988.
2. 2 Berguer, D. G., Krieg, M.-A., Thiebaud, D., Burckhardt, P., Stumpe, F., Hurni, M., Sadeghi, H., Kappenberger, L., and Goy, J. J. Osteoporosis in heart transplant recipients: A longitudinal study. Transplant Proc 26:2649-2651; 1994.
3. 3. Fastell, R. Management of corticosteroid-induced osteoporosis. J Intern Med 217:439-447; 1995.
4. 4. Epstein, S., Schlosberg, M., Fallon, M., Thomas, S., Movsowitz, C., and Ismail, F. 1.25-Dihydroxyvitamin D3 modifies cyclosporine-induced bone loss. Calcif Tissue Int 47:152-157; 1990.
5. 5. Epstein, S., Shane, E., and Bilezikian, J. P. Organ transplantation and osteoporosis. Curr Opin Rheumatol 7:255-261; 1995.
6. 6. Finkelstein, J. S., Klibanski, A., Necr. R. M., Doppelt, S. H., Rosenthal, D. I., Segre, G. V., and Crowley, W. F. Increases in bone density during treatment of men with idiopathic hypogonadotrophic hypogonadism. J Clin Endocrinol Metab 69:776-782; 1989.
7. 7. Gumoulin, G., Hory, B., Nguyen, N. U., Henriet, M. T., Bresson, C., Regnard, J., and Saint-Hilles, R. Lack of evidence that eyclosporine treatment impairs calcium-phosphorus homeostasis and bone remodelling in normocalcemic long-term renal transplant recipients. Transplantation 59:1690-1694; 1995.
8. 8. Guo, C-Y., Jones, T. H., and Eastell, R. Treatment of isolated hypogonadotropic hypogonadism: Effect on bone mineral density and bone turnover. J Clin Endocrinol Metab 82:658-665; 1997.
9. 9. Henderson, N. K., Sambrook, P. N., Kelly, P. J., Macdonald, P., Keogh, A. M., Stratt, P., and Eisman, J. A. Bone mineral loss and recovery after cardiac transplantation. Lancet 346:905; 1995.
10. 10. Jackson, J. A., Kleerekoper, M. Parfitt, A. M., Rao, A. S., Villanueva, A. R., and Frame, B. Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis. J Clin Endocrinol Metab 65:53-58; 1987.
11. 11. Kahan, B. D. Cyclosporine, N Engl J Med 321:1725-1738; 1989.
12. 12. Katznelson, L., Finkelsten, J. S., Schoenfeld, D. A., Rosenthal, D. I., Anderson, E. J., and Klibanski, A. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab 81:4358-4365; 1996.
13. 13. Khosla, S. and Melton, L. J., III. Secondary osteoporosis. In: Riggs, B. I., and Mellon, L. J. III, Eds. Osteoporosis, Etiology. Diagnosis and Management. 2nd ed. Philadelphia: Lippincott-Raven: 1995; 185.
14. 14. Klaushofer, K., Hoffmann, O., and Stewart, P. J. Cyclosporine A inhibits bone resorption in cultured neonatal mouse calvaria. J Pharmacol Exp Ther 243: 584-590; 1987.
15. 15. Leboff, M. S., Wade, J. P., and Mackowiak, S. Low dose prednisone does not affect calcium homeostasis or bone density in postmenopausal women with rheumatoid arthritis. J Rheumatol 18:339-344; 1991.
16. 16. Lee, A. H., Mull, R., Keenan, G., Callegari, P., Dalinka, M. K., Elsen, H. J., Mancini, D. M., Disesa, V. J., and Attie, M. F. Osteoporosis and bone morbidity in cardiac transplant recipients. Am J Med 96:35-40; 1994.
17. 17. Lobo, P. I., Cortez, M. S., Stevenson, W., and Pruett, T. L. Normocalcemic hyperparathyroidism associated with relatively low 1.25 vitamin D levels post-renal transplant can be successfully treated with oral calcitriol. Clin Transplant 9:277-281: 1995.
18. 18. Meys, E., Terreaux-Duvert, F., Beaume-Six, T., Dureau, G., and Meunier, P. J. Bone loss after cardiac transplantation: Effects of calcium, calcidiol and monofluorophosphate. Osteopor Int 3:322-329; 1993.
19. 19. Movsowitz, C., Epstein, S., Fallon, M., Ismail, F., and Thomas, S. Cyclosporin a in vitro produces severe osteopenia in the rat: Effect of dose and duration of administration. Endocrinology 123:2571-2577; 1988.
20. 20. Movsowitz, C., Epstein, S., Ismail, F., Fallon, M., and Thomas, S. Cyclosporine A in the oophorectomzed rat: Unexpected severe bone resorption. J Bone Miner Res 4:393-398; 1989.
21. 21. Rich, G. M., Mudge, G. H., Laffel, G. L., and LeBoff, M. S. Cyclosporine A and prednisone-associated osteoporosis in heart transplant recipients. J Heart Lung Transplant 11:950-958; 1992.
22. 22. Rosalki, S. B. and Foo, A. Y. Two new methods for separating and quantifying bone and liver alkaline phosphatase isoenzymes in plasma. Clin Chem 30: 1182-1186; 1984.
23. 23. Sambrook, P. N., Eisman, J. A., Champion, G. D., Pocock, N. A., Yeates, M. G., and Eberl, S. Osteoporosis in rheumatoid arthritis. Safety of low dose corticosteroids. Ann Rheum Dis 45:950-953; 1986.
24. 24. Sambrook, P. N., Kelly, P. J., Fontana, D., Nguyen, T., Keogh, A., Macdonald, M., Spratt, P., Freand, J., and Eisman, J. A. Mechanisms of rapid bone loss following cardiac transplantation. Osteopor Int 4:273-276; 1994.
25. 25. Sambrook, P. N., Kelly, P. J., Keogh, A. M., Macdonald, M., Spratt, P., Freund, J., and Eisman, J. A. Bone loss after heart transplantation: A prospective study. J Heart Lung Transplant 13:116-121; 1994.
26. 26. Schlosberg, M., Movsowitz, C., Epstein, S., Ismail, F., Fallon, M. D., and Thomas, S. The effect of cyclosporin A administration and its withdrawal on bone mineral metabolism in the rat. Endocrinology 124:2179-2184; 1989.
27. 27. Shane, E., Rivas, M., McMahon, D. J., Staron, R. B., Silverberg, S. J., Seibel, M. J., Mancini, D., Michler, R. E., Aaronson, K., Addesso, V., and Lo, S. H. Bone loss and turnover after cardiac transplantation. J Clin Endocrinol Metab 82:1497-1506; 1997.
28. 28. Shane, E., Rivas, M. C., Silverberg, S. J., Kim, T. S., Staron, R. B., and Bilezikian, J. P. Osteoporosis after cardiac transplantation. Am J Med 94:257-264; 1992.
29. 29. Shane, E., Rivas, M., Staron, R. B., Silverberg, S. J., Seibel, M. J., Kuiper, J., Mancini, D., Addesso, V., Michler, R. E., and Factor-Litvak, P. Fracture after cardiac transplantation: A prospective longitudinal study. J Clin Endocrinol Metab 81:1740-1746; 1996.
30. 30. Stewart, P. J. and Sterm, P. H. Inhibition of parathyroid hormone and interleukin 1 stimulated bone resorption by cyclosporine A but not by cyclosporine H or F. Transplant Proc 20:989-992; 1988.
31. 31. Stewart, P. J. and Sterm, P. H. Interaction of cyclosporine A and calcitonin on bone resorption in vitro. Horm Metab Res 21:194-197; 1989.
32. 32. Steiner, R. W., Ziegler, M., Halasz, N. A., Catherwood, B. D., Manolagass, S., and Deftos, L. J. Effect of daily oral vitamin D and calcium therapy, hypophosphatemia. and endogenous 1.25 dihydroxychlecalciferol on parathyroid hormone and phosphate wasting in renal transplant recipients. Transplantation 56:843-846; 1993.
33. 33. Young, N. R., Baker, M. W. G., Liu, G. D., and Seeman, E. Body composition and muscle strength in healthy men receiving testosterone enanthate for contraception. J Clin Endocrinol Metab 77:1028-1032; 1993.